KIRSCH ARTHUR S — SEC Form 4 filings
SEC reporting owner CIK 1290976. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-08.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-06-24 to 2026-07-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,000 shares, $133,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 30,000 shares, $1,731,300 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 15,000 shares @ $60.22 ($903,300) in Liquidia Corp, filed 2026-06-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Liquidia Corp (LQDA) | Director | 4 | — | 3 legs · 30,000 sh · $1,731,300 | 3 |
| Evommune, Inc. (EVMN) | Director | 3 | 1 leg · 10,000 sh · $133,000 | — | 2 |
| Atea Pharmaceuticals, Inc. (AVIR) | Director | 2 | — | — | 3 |
Form 4 filings — KIRSCH ARTHUR S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-08 | 4 | Evommune, Inc. (EVMN) | Purchase (P): 10,000 @ $13.30 | EDGAR |
| 2026-06-23 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 5,882 @ $0 | EDGAR |
| 2026-06-03 | 4 | Liquidia Corp (LQDA) | Sale (S): 15,000 @ $60.22 · Sale (S): 5,000 @ $56 · Sale (S): 10,000 @ $54.80 | EDGAR |
| 2026-06-03 | 4 | Evommune, Inc. (EVMN) | Grant/award (A): 15,673 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | Evommune, Inc. (EVMN) | Grant/award (A): 37,960 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 18,396 @ $0 | EDGAR |
| 2025-02-24 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 164,800 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 20,359 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1290976 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →